two ways you can choose for treating chronic kidney disease
Chronic kidney disease treatment for many people is a nightmare, the course of treatment of this disease is relatively long, and it is not an independent disease, it will affect other organs. Treatment of chronic nephritis can choose drug and non-drug approach, we take a detailed look at it.
Both treatment of chronic kidney disease selectable
Treatment of chronic kidney disease ① non-drug treatment: limit sodium intake diet, patients with hypertension should limit sodium (<3g / day), sodium intake to 80 ~ 100mmol, antihypertensive drugs should be restricted sodium diet conducted on the basis of dietary protein and potassium adjust food intake. Smoking, limiting alcohol consumption, diet, proper exercise.
② therapeutic treatment of chronic kidney disease: Commonly used antihypertensive drugs angiotensin-converting enzyme inhibitors (ACEl), angiotensin Ⅱ receptor antagonist (ARB), long-acting calcium channel blocker (CCB), a diuretic agents, blockers. Because of ACEI and ARB in addition to a role in lowering blood pressure, there is reduction in proteinuria and renal protective effect of delaying the deterioration of renal function should be preferred. ACEI and ARB use drugs should be periodic testing of blood pressure, renal function and serum potassium. Some patients first application of ACEI and ARB elevated serum creatinine occurs about two weeks, you need to check for risk factors, if not exceed the base level of 30%, you can still continue to apply. There are bilateral renal artery stenosis were banned. Patients with renal insufficiency ACEI and ARB carefully, with particular attention to prevention of hyperkalemia. ACEI few patients have adverse reactions to persistent dry cough, you can switch to ARB class.
Chronic kidney disease is a relatively common disease of Nephrology, suffering from chronic kidney disease, the treatment of certain measures to do. Hope more of these treatments for chronic kidney disease, allowing patients got better.
没有评论:
发表评论